An oldie but a goodie -- thought it was worth repeating!
In a position statement from the American Diabetes Association and the European Association for the Study of Diabetes, published in both Diabetes Care and Diabetologia (2012), clinicians are urged to take an individualized, patient-centric approach when treating type 2 diabetes. GO FIGURE? You mean we weren’t all stamped out in a cookie press??
So the thinking NOW is that both HbA1c targets and pharmaceutical interventions should be tailored to patients’ needs and preferences. WHAT A CONCEPT!
For a long time, the national groups have been pushing towards a cookie cutter approach in an attempt to improve overall outcomes. But oddly enough, a disease process stemming from a multifactorial risk set does not routinely respond to treatment in a cookie cutter fashion. As such, if you actually took care of people, you already knew that you had to tailor therapy to the individual — if not for the fact that people had side effects, bad insurance coverage, you name it.
Who knew? The next thing you know, there’ll be an ice store with 31 flavors…. ; )
Bruce L. Feldman, MD
Dr Bruce is an advocate for health. You need to be your own health advocate. His blog offers his opinions and insights on numerous topics he believes might be of interest. Hope you agree!